HOUSTON, Nov. 1, 2024
/PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company")
(NASDAQ: NUTX), a physician-led, integrated healthcare delivery
system comprised of 22 state-of-the-art micro hospitals in 10
states and primary care-centric, risk-bearing physician networks,
today announced that it will release financial results for the
third quarter ended September 30,
2024 after the close of the stock market on Thursday, November 7, 2024. The Company will
discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET.
Participant Listening: 1-877-407-9208 or
1-201-493-6784
Participant webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06250d
To access the call, please dial in approximately five minutes
before start time. Those who are unable to attend the live
conference call may access the recording on the Company's
website.
About Nutex Health Inc.
Headquartered in Houston, Texas and founded in 2011,
Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and
operations company with two divisions: a Hospital Division and a
Population Health Management Division.
The Hospital Division owns, develops and operates innovative
health care models, including micro-hospitals, specialty hospitals,
and hospital outpatient departments (HOPDs). This division owns and
operates 22 facilities in 10 states.
The Population Health Management division owns and operates
provider networks such as Independent Physician Associations
(IPAs). We provide management, administrative and other support
services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "expects to," "will continue," "anticipated,"
"estimate," "projected," "intend," "goal," or similar expressions
are intended to identify "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements are subject to certain risks, known and unknown,
and uncertainties, many of which are beyond the control of the
Company. Such uncertainties and risks include, but are not limited
to, our ability to successfully execute our growth strategy,
changes in laws or regulations, including final rules implemented
under the No Surprises Act and related regulatory guidance,
economic conditions, dependence on management, dilution to
stockholders, lack of capital, the effects of rapid growth upon the
Company and the ability of management to effectively respond to the
growth and demand for products and services of the Company, newly
developing technologies, the Company's ability to compete,
conflicts of interest in related party transactions, regulatory
matters, protection of technology, lack of industry standards, the
effects of competition and the ability of the Company to obtain
future financing. An extensive list of factors that can affect
future results are discussed in the Annual Report on Form 10-K for
the year ended December 31, 2023 and
in the Quarterly Report on Form 10-Q for the period ended
September 30, 2024 under the heading
"Risk Factors" in Part I, Item IA thereof, and other documents
filed from time to time with the Securities and Exchange
Commission. Such factors could materially adversely affect the
Company's financial performance and could cause the Company's
actual results for future periods to differ materially from any
opinions or statements expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-schedules-2024-third-quarter-financial-results-release-and-conference-call-302293911.html
SOURCE Nutex Health, Inc.